Skip to main content
SpringerLink
Log in

Hyperpigmentierung des Gesichts

  • Wie lautet Ihre Diagnose?
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Ahmad S (1995) Amiodarone and reversible alopecia. Arch Intern Med 155:1106

    Article  CAS  PubMed  Google Scholar 

  2. Ahuja SR, Sharma RA (2003) Reversible cutaneous hyperpigmentation in vitamin B12 deficiency. Indian Pediatr 40:170–171

    PubMed  Google Scholar 

  3. Ammann R, Braathen LR (1996) Amiodaron pigmentation. Hautarzt 47:930–931

    Article  CAS  PubMed  Google Scholar 

  4. Banba K, Tanaka N, Fujioka A, Tajima S (1999) Hyperpigmentation caused by hyperthyroidism: differences from the pigmentation of Addison's disease. Clin Exp Dermatol 24:196–198

    Article  CAS  PubMed  Google Scholar 

  5. Bohm M, Schmidt PF, Lodding B et al. (2002) Cutaneous hyperpigmentation induced by doxycycline: histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence. Am J Dermatopathol 24:345–350

    Article  PubMed  Google Scholar 

  6. Briganti S, Camera E, Picardo M (2003) Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16:101–110

    Article  PubMed  Google Scholar 

  7. Burches E, Garcia-Verdegay F, Ferrer M, Pelaez A (2000) Amiodarone-induced angioedema. Allergy 55:1199–1200

    Article  CAS  PubMed  Google Scholar 

  8. Dereure O (2001) Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol 2:253–262

    CAS  PubMed  Google Scholar 

  9. Geerts ML (1971) Amiodarone pigmentation. An electron microscopic study. Arch Belg Dermatol Syphiligr 27:339–351

    CAS  PubMed  Google Scholar 

  10. Guerciolini R, Del Favero A, Cannistraro S (1984) Amiodarone-induced photosensitivity and pyridoxine. Lancet 1:962

    CAS  Google Scholar 

  11. Honegger UE, Scuntaro I, Wiesmann UN (1995) Vitamin E reduces accumulation of amiodarone and desethylamiodarone and inhibits phospholipidosis in cultured human cells. Biochem Pharmacol 49:1741–1745

    Article  CAS  PubMed  Google Scholar 

  12. Katoulis AC, Stavrianeas NG, Katsarou A et al. (2002) Evaluation of the role of contact sensitization and photosensitivity in the pathogenesis of poikiloderma of Civatte. Br J Dermatol 147:493–497

    Article  CAS  PubMed  Google Scholar 

  13. Kaufmann G (1984) Pyridoxine against amiodarone-induced photosensitivity. Lancet 1:51–52

    CAS  Google Scholar 

  14. Kazantzis G (2002) Mercury exposure and early effects: an overview. Med Lav 93:139–147

    CAS  PubMed  Google Scholar 

  15. Korting HC, Kolz R, Schmoeckel C, Balda BR (1981) Amiodaronepigmentierung. Eine seltene, aber typische Medikamentenwirkung. Hautarzt 32:301–305

    Google Scholar 

  16. Kounis NG, Frangides C, Papadaki PJ et al. (1996) Dose-dependent appearance and disappearance of amiodarone-induced skin pigmentation. Clin Cardiol 19:592–594

    CAS  PubMed  Google Scholar 

  17. Kowey PR, Marinchak RA, Rials SJ, Filart RA (1997) Intravenous amiodarone. Am Coll Cardiol 29:1190–1198

    Article  CAS  Google Scholar 

  18. Lada-Jagas R, Pysz J (1969) Toxic coloration of the skin (melanodermatitis toxica Habermann-Hoffmann) in workers exposed to photosensitizing agents. Wiad Lek 22:181–183

    CAS  PubMed  Google Scholar 

  19. Levin CY, Maibach H (2001) Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol 2:213–217

    CAS  PubMed  Google Scholar 

  20. Loddenkemper K, Buttgereit F (2002) Chrysiasis. Z Rheumatol 61:173–174

    Article  CAS  PubMed  Google Scholar 

  21. Loewe R, Puspok-Schwarz M, Petzelbauer P (2003) Apomorphin Hyperpigmentation. Hautarzt 54:58–63

    CAS  PubMed  Google Scholar 

  22. Miller RA, McDonald AT (1984) Dermal lipofuscinosis associated with amiodarone therapy. Report of a case. Arch Dermatol 120:646–649

    Article  CAS  PubMed  Google Scholar 

  23. Ming ME, Bhawan J, Stefanato CM et al. (1999) Imipramine-induced hyperpigmentation: four cases and a review of the literature. J Am Acad Dermatol 40:159–166

    CAS  PubMed  Google Scholar 

  24. Möller-Vietheer M, Goos M (1977) Erythema dyschromicum perstans. Hautarzt 28:539–541

    PubMed  Google Scholar 

  25. Muir AD (1982) Amiodarone and psoriasis. N Z Med J 95:711

    CAS  PubMed  Google Scholar 

  26. Niederau C, Stremmel W, Strohmeyer GW (1994) Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol 7:881–901

    CAS  PubMed  Google Scholar 

  27. Parodi A, Guarrera M, Rebora A (1988) Amiodarone-induced pseudoporphyria. Photodermatol 5:146–147

    CAS  PubMed  Google Scholar 

  28. Paul PC, Chattopadhyay A, Dutta SK et al. (2000) Histopathology of skin lesions in chronic arsenic toxicity-grading of changes and study of proliferative markers. Indian J Pathol Microbiol 43:257–264

    CAS  PubMed  Google Scholar 

  29. Pichler WJ, Schindler L, Staubli M et al. (1988) Anti-amiodarone antibodies: detection and relationship to the development of side effects. Am J Med 85:197–202

    CAS  PubMed  Google Scholar 

  30. Primka EJ, Liranzo MO, Bergfeld WF, Dijkstra JW (1994) Amiodarone-induced linear IgA disease. J Am Acad Dermatol 3:809–811

    Google Scholar 

  31. Rappersberger K, Konrad K, Wieser E et al. (1986) Morphological changes in peripheral blood cells and skin in amiodarone-treated patients. Br J Dermatol 114:189–196

    CAS  PubMed  Google Scholar 

  32. Ricci C, Krasovec M, Frenk E (1997) Amiodarone induced iododerma treated by cyclosporine. Ann Dermatol Venereol 124:260–263

    CAS  PubMed  Google Scholar 

  33. Sarkar R, Jain RK, Puri P (2003) Melasma in Indian males. Dermatol Surg 29:204

    Article  PubMed  Google Scholar 

  34. Scharf C, Oechslin EN, Salomon F, Kiowski W (2001) Clinical picture: Amiodarone-induced pulmonary mass and cutaneous vasculitis. Lancet 358:2045

    Article  CAS  PubMed  Google Scholar 

  35. Serrano G, Pujol C, Cuadra J et al. (1989) Riehl's melanosis: pigmented contact dermatitis caused by fragrances. J Am Acad Dermatol 21:1057–1060

    CAS  PubMed  Google Scholar 

  36. Sheikhzadeh A, Schafer U, Schnabel A (2002) Drug-induced lupus erythematosus by amiodarone. Arch Intern Med 162:834–836

    Article  PubMed  Google Scholar 

  37. Sue YM, Lee JY, Wang MC et al. (2001) Generalized argyria in two chronic hemodialysis patients. Am J Kidney Dis 37:1048–1051

    CAS  PubMed  Google Scholar 

  38. Trappe HJ (2001) Amiodaron. Intensivmed 38:169–178

    Article  Google Scholar 

  39. Trojan A, Borelli S (2002) Adverse chemotherapy effects on skin and mucous membranes. Schweiz Rundsch Med Prax 91:1078–1087

    CAS  PubMed  Google Scholar 

  40. Uebermuth CA, Gerke E (2002) First unilateral, later bilateral optic neuropathy. Amiodarone as the cause? Ophthalmologe 99:470–473

    CAS  PubMed  Google Scholar 

  41. Vestesaeger M, Gillot G, Rasson G (1967) Etude clinique d'une nouvelle medication anti-angoreuse. Acta Cardiol 22:483–500

    Google Scholar 

  42. Vorperian VR, Havighurst TC, Miller S, January CT (1997) Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30:791–798

    Article  CAS  PubMed  Google Scholar 

  43. Wohlrab J, Fischer M, Stoldt G, Marsch WC (2001) 52-year old patient with skin discoloration. Internist 42:1256–1260

    Article  CAS  PubMed  Google Scholar 

  44. Yung A, Agnew K, Snow J, Oliver F (2002) Two unusual cases of toxic epidermal necrolysis. Australas J Dermatol 43:35–38

    Article  PubMed  Google Scholar 

  45. Zachary CB, Slater DN, Holt DW et al. (1984) The pathogenesis of amiodarone-induced pigmentation and photosensitivity. Br J Dermatol 110:451–456

    CAS  PubMed  Google Scholar 

  46. Zaynoun ST, Aftimos BA, Tenekjian KK, Kurban AK (1981) Berloque dermatitis—a continuing cosmetic problem. Contact Dermat 7:111–116

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatologische Klinik und Poliklinik des Universitätsklinikums Essen, Essen

    J. Dissemond, T. Franckson, G. Fitz, U. Hillen & M. Goos

  2. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Essen, Hufelandstraße 55, 45147 , Essen

    J. Dissemond

Authors
  1. J. Dissemond
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Franckson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Fitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Hillen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Goos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Dissemond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dissemond, J., Franckson, T., Fitz, G. et al. Hyperpigmentierung des Gesichts. Hautarzt 54, 994–998 (2003). https://doi.org/10.1007/s00105-003-0603-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-003-0603-5

Search

Navigation